Anthropic, PBC filed a Form S-8 registration statement with the Securities and Exchange Commission on November 19, 2026, registering 121,886,381 shares of Class A common stock for potential resale by current and former employees, directors, consultants, and advisors under its Amended and Restated 2021 Stock Plan.

Key Highlights

  • Shares registered: 121,886,381 shares of Class A common stock, $0.00001 par value per share, covered by the reoffer prospectus.
  • IPO price: The initial public offering price of the Class A common stock was $83.00 per share, pursuant to a Form S-1 (File No. 333-299633) declared effective on November 18, 2026.
  • Exchange listing: The Class A common stock has been approved for listing on the Nasdaq Global Select Market under the symbol "ANT," according to the filing.
  • No company proceeds: The company disclosed it will not receive any proceeds from the sale of shares by the Selling Stockholders under this prospectus.
  • Resale limit: Each Selling Stockholder's resales are subject to a cap: during any three-month period, the amount may not exceed the quantity specified in Rule 144(e) under the Securities Act.
  • Plan source: The shares were acquired, or in certain cases will be acquired, by the Selling Stockholders pursuant to the Amended and Restated 2021 Stock Plan.

Anthropic's Post-IPO Resale Registration and Reoffer Prospectus Details

Anthropic, PBC (NASDAQ:ANT), incorporated as a Delaware public benefit corporation in January 2021, filed this Form S-8 registration statement one day after its Form S-1 was declared effective. According to the filing, the registration statement includes a reoffer prospectus prepared in accordance with Part I of Form S-3, and covers shares that constitute "control securities" or "restricted securities" within the meaning of the Securities Act of 1933, as amended. The Selling Stockholders, described as current and former employees, directors, consultants, and advisors, may offer the shares for their own accounts on a continuous or delayed basis.

The filing states that the Selling Stockholders may sell shares "in a number of different ways and at varying prices, including sales in the open market, sales in negotiated transactions, and sales by a combination of these methods." The price at which any shares may be sold and any associated commissions are described as unknown and variable from transaction to transaction. If underwriters or dealers are used, the filing indicates those parties will be named and their compensation described in a prospectus supplement. The Selling Stockholders will bear all sales commissions and similar expenses, while Anthropic will bear any other registration and offering expenses not borne by the Selling Stockholders.

Anthropic described itself in the filing as "first and foremost a research lab," with a stated mission of "the responsible development and maintenance of advanced AI for the long-term benefit of humanity." The company noted its principal executive offices are located at 548 Market Street, PMB 90375, San Francisco, California 94104. The filing identifies Dario Amodei, Chief Executive Officer and Co-Founder, and Daniela Amodei, President and Co-Founder, as agents for service. The filing notes that the SEC "may take the view that, under certain circumstances, the Selling Stockholders and any broker-dealers or agents that participate with the Selling Stockholders in the distribution of the Shares may be deemed to be 'underwriters' within the meaning of the Securities Act."

What Was Disclosed

Anthropic, PBC filed a Form S-8 on November 19, 2026, registering 121,886,381 Class A common shares for resale by Selling Stockholders under its 2021 Stock Plan. The company will not receive proceeds from these potential resales, and per-share resale prices will vary by transaction.